Unlocking Targeted Delivery. Redefining Therapeutics.

Navicyte is pioneering a first-in-class drug delivery platform that safely and effectively directs immune-targeted therapeutics.

Our Platform

At Navicyte, we are reinventing how immune-modulating drugs are delivered to increase efficacy, safety, and flexibility for drug developers.

Navicyte offers

Efficacy. Expands therapeutic index by more than 500-fold in pre-clinical models.
Flexibility. Compatible with small molecules, proteins, nucleic acids, vaccines, and adjuvants.
Safety. Reduces off-target exposure and lowers required therapeutic doses by up to 85%.
Innovation. Tunable release kinetics and immune-targeted delivery with FDA/GMP manufacturing compatibility.